- Generic name
- Ondansetron
- Strength
- 4 mg
- Dosage form
- Orodispersible Tablet
- Manufactured by
- Advanced Chemical Industries PLC
Osetron ODT Orodispersible Tablet
About Osetron ODT 4 mg Orodispersible Tablet
Osetron ODT 4 mg is an orodispersible tablet that helps prevent nausea and vomiting. It works by blocking a body signal that triggers the vomiting reflex.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Osetron ODT 4 mg Orodispersible Tablet?
Osetron ODT 4 mg is an orodispersible tablet made by Advanced Chemical Industries PLC. It contains ondansetron, an anti-emetic medicine. This type of medicine blocks a serotonin signal in the body that can start the vomiting reflex, which may be triggered by chemotherapy, radiotherapy or surgery. It comes as a tablet that dissolves in the mouth. The doctor decides the dose and course for each person. Always follow the doctor's instructions and ask a pharmacist if you are unsure about anything.
Uses of Osetron ODT
Osetron ODT 4 mg is used to prevent nausea and vomiting linked to cancer chemotherapy and radiotherapy. It is also used to prevent and treat nausea and vomiting after surgery. It is not a general stomach-settling medicine for every cause of sickness, and it should not replace other treatments your doctor has planned. Ask your doctor whether it is suitable for your situation.
How to use Osetron ODT
Osetron ODT 4 mg is an orodispersible tablet, so it is placed on the tongue and left to dissolve. The doctor decides the dose and how long you take it. Do not change the dose or stop on your own. If you forget a dose, ask your doctor or pharmacist what to do. Tell your doctor about all other medicines you take, because some medicines can affect how ondansetron works in the body.
Side effects of Osetron ODT
Common side effects include headache, constipation and diarrhoea, and most are mild or moderate. Some people may notice a feeling of flushing or warmth, hiccups, or changes in liver enzyme tests. Rarely, serious reactions such as allergic reactions, wheezing, fast heartbeat, chest pain, low potassium or shortness of breath have been reported. Tell your doctor if you have any side effect that worries you or does not go away.
Safety and precautions
Osetron ODT 4 mg should not be used by anyone who is allergic to ondansetron or any ingredient in the tablet, or who is taking apomorphine. Tell your doctor if you have had allergic reactions to similar anti-sickness medicines. It may hide signs of a bowel problem after abdominal surgery, so the doctor should know your history. There are no adequate, well-controlled studies in pregnant women, so ask your doctor before use if you are pregnant, planning pregnancy or breastfeeding. Your doctor will decide whether it is suitable for you.
Frequently asked questions
Is Osetron ODT 4 mg safe in pregnancy or breastfeeding?
There are no adequate, well-controlled studies of ondansetron in pregnant women. If you are pregnant, planning pregnancy or breastfeeding, tell your doctor before taking Osetron ODT 4 mg. Your doctor will decide whether it is suitable for you and will explain the possible risks and benefits.
What is Osetron ODT 4 mg used for and what kind of medicine is it?
Osetron ODT 4 mg is an anti-emetic medicine containing ondansetron. It is used to prevent nausea and vomiting caused by cancer chemotherapy or radiotherapy, and to prevent and treat nausea and vomiting after surgery. It works by blocking a body signal that can start the vomiting reflex.
Who should avoid Osetron ODT 4 mg or ask the doctor first?
Do not take it if you are allergic to ondansetron or any ingredient, or if you take apomorphine. Ask your doctor first if you have had allergic reactions to similar medicines, have had abdominal surgery, have a bowel problem, or are pregnant or breastfeeding. The doctor decides if it is right for you.
How should I take Osetron ODT 4 mg and what if I miss a dose?
Place the orodispersible tablet on your tongue and let it dissolve. The doctor decides the dose and the course. Do not change the dose yourself. If you miss a dose, ask your doctor or pharmacist what to do. Tell your doctor about all other medicines you take.
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.